Possible Association between the Use of Proton Pump Inhibitors and H₂ Receptor Antagonists, and Esophageal Cancer: A Nested Case-Control Study Using a Korean National Health Screening Cohort

• Main Authors: Hyo Geun Choi (Author), Hong Kyu Lee (Author), Ho Suk Kang (Author), Hyun Lim (Author), Joo-Hee Kim (Author), Ji Hee Kim (Author), Nan Young Kim (Author), Seong-Jin Cho (Author), Eun Sook Nam (Author), Kyueng-Whan Min (Author), Mi Jung Kwon (Author)
• Formato: Livro
• Publicado em: MDPI AG, 2022-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Although safety concerns regarding proton pump inhibitor (PPI)/H2-receptor antagonists (H2RA) in the incident esophageal cancer have been raised, the Asian-based report is unclear. We investigated the estimated likelihood of incident esophageal cancer-its mortality depending on prior history of PPI/...